LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

PRELUDE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001387508)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 25,304 Value ($000) $56 Avg Close — Range —
Q4 2023
Shares 17,504 Value ($000) $34 Avg Close — Range —
Q2 2023
Shares 12,754 Value ($000) $41 Avg Close — Range —
Q1 2023
Shares 31,000 Value ($000) $73 Avg Close — Range —